Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 13
2004 11
2005 7
2006 8
2007 6
2008 8
2009 11
2010 6
2011 10
2012 7
2013 4
2014 4
2015 8
2016 6
2017 6
2018 6
2019 5
2020 9
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Results by year
Filters applied: . Clear all
Page 1
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.
Yamamoto M, Kiso M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Takeda M, Kinoshita N, Ohmagari N, Gohda J, Semba K, Matsuda Z, Kawaguchi Y, Kawaoka Y, Inoue JI. Yamamoto M, et al. Among authors: inoue ji. Viruses. 2020 Jun 10;12(6):629. doi: 10.3390/v12060629. Viruses. 2020. PMID: 32532094 Free PMC article.
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.
Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z. Yamamoto M, et al. Among authors: inoue ji. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539. doi: 10.1128/AAC.01043-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27550352 Free PMC article.
139 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page